Skip to main content
SpringerLink
Log in

Bacteria

  • Chapter
Book cover Molecular Pathology of Lung Diseases

Part of the book series: Molecular Pathology Library ((MPLB,volume 1))

  • 2150 Accesses

Abstract

This chapter begins with a general description of the etiology, pathogenesis, pathology, clinical features, and diagnosis of bacterial pneumonia. Specifics of pathogenesis, clinical features, antibiotic resistance, and diagnostic testing for the important bacterial causes of community-acquired pneumonia are then discussed.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 299.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. White NJ. Melioidosis. Lancet 2003;361(9370):1715–1722.

    Article  CAS  PubMed  Google Scholar 

  2. Parker NR, Barralet JH, Bell AM. Q fever. Lancet 2006;367(9511):679–888.

    Article  PubMed  Google Scholar 

  3. Rotz LD, Khan AS, Lillibridge SR, et al. Public health assessment of potential biological terrorism agents. Emerg Infect Dis 2002;8(2):225–230.

    Article  PubMed  Google Scholar 

  4. Husain AN, Kumar V. The Lung. In Kumar V, Abbas AK, Fausto N, eds. Robbins and Cotran Pathologic Basis of Disease, 7th ed. Philadelphia: Elsevier Saunders; 2005:711–772.

    Google Scholar 

  5. Moore-Gillon J. The Respiratory System. In Swash M, ed. Hutchison’s Clinical Methods, 21st ed. London: Elsevier Saunders; 2002:60–78.

    Google Scholar 

  6. Reimer LG, Carroll KC. Role of the microbiology laboratory in the diagnosis of lower respiratory tract infections. Clin Infect Dis 1998;26(3):742–748.

    Article  CAS  PubMed  Google Scholar 

  7. Stralin K, Tornqvist E, Kaltoft MS, et al. Etiologic diagnosis of adult bacterial pneumonia by culture and PCR applied to respiratory tract samples. J Clin Microbiol 2006;44(2):643–645.

    Article  PubMed  Google Scholar 

  8. Oosterheert JJ, van Loon AM, Schuurman R, et al. Impact of rapid detection of viral and atypical bacterial pathogens by real-time polymerase chain reaction for patients with lower respiratory tract infection. Clin Infect Dis 2005;41(10):1438–1444.

    Article  PubMed  Google Scholar 

  9. Jedrzejas MJ. Pneumococcal virulence factors: structure and function. Microbiol Mol Biol Rev 2001;65(2):187–207.

    Article  CAS  PubMed  Google Scholar 

  10. Doern GV, Pfaller MA, Kugler K, et al. Prevalence of antimicrobial resistance among respiratory tract isolates of Streptococcus pneumoniae in North America: 1997 results from the SENTRY antimicrobial surveillance program. Clin Infect Dis 1998;27(4):764–770.

    Article  CAS  PubMed  Google Scholar 

  11. Jacobs MR. Streptococcus pneumoniae: epidemiology and patterns of resistance. Am J Med 2004;117Suppl 3A:3S–15S.

    CAS  PubMed  Google Scholar 

  12. Kalin M, Lindberg AA. Diagnosis of pneumococcal pneumonia: a comparison between microscopic examination of expectorate, antigen detection and cultural procedures. Scand J Infect Dis 1983;15(3):247–255.

    CAS  PubMed  Google Scholar 

  13. Murdoch DR. Molecular genetic methods in the diagnosis of lower respiratory tract infections. APMIS 2004;112(11–12):713–727.

    Article  CAS  PubMed  Google Scholar 

  14. Rao VK, Krasan GP, Hendrixson DR, et al. Molecular determinants of the pathogenesis of disease due to nontypable Haemophilus influenzae. FEMS Microbiol Rev 1999;23(2):99–129.

    CAS  PubMed  Google Scholar 

  15. Sethi S, Murphy TF. Bacterial infection in chronic obstructive pulmonary disease in 2000: a state-of-the-art review. Clin Microbiol Rev 2001;14(2):336–363.

    Article  CAS  PubMed  Google Scholar 

  16. Hoban DJ, Doern GV, Fluit AC, et al. Worldwide prevalence of antimicrobial resistance in Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the SENTRY Antimicrobial Surveillance Program, 1997–1999. Clin Infect Dis 2001;32Suppl 2:S81–S93.

    Article  CAS  PubMed  Google Scholar 

  17. Williams JD, Moosdeen F. Antibiotic resistance in Haemophilus influenzae: epidemiology, mechanisms, and therapeutic possibilities. Rev Infect Dis 1986;8Suppl 5:S555–S61.

    CAS  PubMed  Google Scholar 

  18. Ehrhardt AF, Russo R. Clinical resistance encountered in the respiratory surveillance program (RESP) study: a review of the implications for the treatment of communityacquired respiratory tract infections. Am J Med 2001;111Suppl 9A:30S–38S.

    Article  PubMed  Google Scholar 

  19. Then RL. Mechanisms of resistance to trimethoprim, the sulfonamides, and trimethoprim-sulfamethoxazole. Rev Infect Dis 1982;4(2):261–269.

    CAS  PubMed  Google Scholar 

  20. Daly JA, Clifton NL, Seskin KC, Gooch WM 3rd. Use of rapid, nonradioactive DNA probes in culture confirmation tests to detect Streptococcus agalactiae, Haemophilus influenzae, and Enterococcus spp. from pediatric patients with significant infections. J Clin Microbiol 1991;29(1):80–82.

    CAS  PubMed  Google Scholar 

  21. Marty A, Greiner O, Day PJ, et al. Detection of Haemophilus influenzae type b by real-time PCR. J Clin Microbiol 2004;42(8):3813–3815.

    Article  CAS  PubMed  Google Scholar 

  22. Bootsma HJ, van der Heide HG, van de Pas S, et al. Analysis of Moraxella catarrhalis by DNA typing: evidence for a distinct subpopulation associated with virulence traits. J Infect Dis 2000;181(4):1376–1387.

    Article  CAS  PubMed  Google Scholar 

  23. Karalus R, Campagnari A. Moraxella catarrhalis: a review of an important human mucosal pathogen. Microbes Infect 2000;2(5):547–559.

    Article  CAS  PubMed  Google Scholar 

  24. Felmingham D, Washington J. Trends in the antimicrobial susceptibility of bacterial respiratory tract pathogens—findings of the Alexander Project 1992–1996. J Chemother 1999;11(Suppl 1):5–21.

    CAS  PubMed  Google Scholar 

  25. Bootsma HJ, van Dijk H, Vauterin P, et al. Genesis of BRO beta-lactamase-producing Moraxella catarrhalis: evidence for transformation-mediated horizontal transfer. Mol Microbiol 2000;36(1):93–104.

    Article  CAS  PubMed  Google Scholar 

  26. Greiner O, Day PJ, Altwegg M, Nadal D. Quantitative detection of Moraxella catarrhalis in nasopharyngeal secretions by real-time PCR. J Clin Microbiol 2003;41(4):1386–1390.

    Article  CAS  PubMed  Google Scholar 

  27. Mandell LA, Bartlett JG, Dowell SF, et al. Update of practice guidelines for the management of community-acquired pneumonia in immunocompetent adults. Clin Infect Dis 2003;37(11):1405–1433.

    Article  PubMed  Google Scholar 

  28. Fliermans CB, Cherry WB, Orrison LH, et al. Ecological distribution of Legionella pneumophila. Appl Environ Microbiol 1981;41(1):9–16.

    CAS  PubMed  Google Scholar 

  29. Rogers J, Keevil CW. Immunogold and fluorescein immunolabelling of Legionella pneumophila within an aquatic biofilm visualized by using episcopic differential interference contrast microscopy. Appl Environ Microbiol 1992;58(7):2326–2330.

    CAS  PubMed  Google Scholar 

  30. Fields BS, Benson RF, Besser RE. Legionella and Legionnaires’ disease: 25 years of investigation. Clin Microbiol Rev 2002;15(3):506–526.

    Article  PubMed  Google Scholar 

  31. Roig J, Rello J. Legionnaires’ disease: a rational approach to therapy. J Antimicrob Chemother 2003;51(5):1119–1129.

    Article  CAS  PubMed  Google Scholar 

  32. Breiman RF, Butler JC. Legionnaires’ disease: clinical, epidemiological, and public health perspectives. Semin Respir Infect 1998;13(2):84–89.

    CAS  PubMed  Google Scholar 

  33. Hayden RT, Uhl JR, Qian X, et al. Direct detection of Legionella species from bronchoalveolar lavage and open lung biopsy specimens: comparison of LightCycler PCR, in situ hybridization, direct fluorescence antigen detection, and culture. J Clin Microbiol 2001;39(7):2618–2626.

    Article  CAS  PubMed  Google Scholar 

  34. Grayston JT, Diwan VK, Cooney M, Wang SP. Community-and hospital-acquired pneumonia associated with Chlamydia TWAR infection demonstrated serologically. Arch Intern Med 1989;149(1):169–173.

    Article  CAS  PubMed  Google Scholar 

  35. Schmidt SM, Muller CE, Mahner B, Wiersbitzky SK. Prevalence, rate of persistence and respiratory tract symptoms of Chlamydia pneumoniae infection in 1211 kindergarten and school age children. Pediatr Infect Dis J 2002;21(8):758–762.

    Article  PubMed  Google Scholar 

  36. Hammerschlag MR. Chlamydia pneumoniae and the lung. Eur Respir J 2000;16(5):1001–1007.

    Article  CAS  PubMed  Google Scholar 

  37. McConnell CT Jr, Plouffe JF, File TM, et al. Radiographic appearance of Chlamydia pneumoniae (TWAR strain) respiratory infections. CBPIS Study Group. Community-Based Pneumonia Incidence Study. Radiology 1994;192(3):819–24.

    PubMed  Google Scholar 

  38. Dowell SF, Peeling RW, Boman J, et al. Standardizing Chlamydia pneumoniae assays: recommendations from the Centers for Disease Control and Prevention (USA) and the Laboratory Centre for Disease Control (Canada). Clin Infect Dis 2001;33(4):492–503.

    Article  CAS  PubMed  Google Scholar 

  39. Wilson MH, Collier AM. Ultrastructural study of Mycoplasma pneumoniae in organ culture. J Bacteriol 1976;125(1):332–339.

    CAS  PubMed  Google Scholar 

  40. Waites KB, Talkington DF. Mycoplasma pneumoniae and its role as a human pathogen. Clin Microbiol Rev 2004;17(4):697–728.

    Article  CAS  PubMed  Google Scholar 

  41. Collier AM. Attachment by mycoplasmas and its role in disease. Rev Infect Dis 1983;5(Suppl 4):S685–S691.

    PubMed  Google Scholar 

  42. Meseguer MA, Perez-Molina JA, Fernandez-Bustamante J, et al. Mycoplasma pneumoniae pericarditis and cardiac tamponade in a ten-year-old girl. Pediatr Infect Dis J 1996;15(9):829–831.

    Article  CAS  PubMed  Google Scholar 

  43. Abramovitz P, Schvartzman P, Harel D, et al. Direct invasion of the central nervous system by Mycoplasma pneumoniae: a report of two cases. J Infect Dis 1987;155(3):482–487.

    CAS  PubMed  Google Scholar 

  44. Foy HM, Grayston JT, Kenny GE, et al. Epidemiology of Mycoplasma pneumoniae infection in families. JAMA 1966;197(11):859–866.

    Article  CAS  PubMed  Google Scholar 

  45. Taylor-Robinson D, Webster AD, Furr PM, Asherson GL. Prolonged persistence of Mycoplasma pneumoniae in a patient with hypogammaglobulinaemia. J Infect 1980;2(2):171–175.

    Article  CAS  PubMed  Google Scholar 

  46. Waites KB, Crabb DM, Duffy LB. Inhibitory and bactericidal activities of gemifloxacin and other antimicrobials against Mycoplasma pneumoniae. Int J Antimicrob Agents 2003;21(6):574–577.

    Article  CAS  PubMed  Google Scholar 

  47. Roberts MC, Koutsky LA, Holmes KK, et al. Tetracyclineresistant Mycoplasma hominis strains contain streptococcal tetM sequences. Antimicrob Agents Chemother 1985;28(1):141–143.

    CAS  PubMed  Google Scholar 

  48. Ieven M, Ursi D, Van Bever H, et al. Detection of Mycoplasma pneumoniae by two polymerase chain reactions and role of M. pneumoniae in acute respiratory tract infections in pediatric patients. J Infect Dis 1996;173(6):1445–1452.

    CAS  PubMed  Google Scholar 

  49. Daxboeck F, Krause R, Wenisch C. Laboratory diagnosis of Mycoplasma pneumoniae infection. Clin Microbiol Infect 2003;9(4):263–273.

    Article  CAS  PubMed  Google Scholar 

  50. Razin S. DNA probes and PCR in diagnosis of mycoplasma infections. Mol Cell Probes 1994;8(6):497–511.

    Article  CAS  PubMed  Google Scholar 

  51. Guris D, Strebel PM, Bardenheier B, et al. Changing epidemiology of pertussis in the United States: increasing reported incidence among adolescents and adults, 1990–1996.Clin Infect Dis1999;28(6):1230–1237.

    Article  CAS  PubMed  Google Scholar 

  52. Schellekens J, von Konig CH, Gardner P. Pertussis sources of infection and routes of transmission in the vaccination era. Pediatr Infect Dis J 2005;24(5 Suppl):S19–S24.

    PubMed  Google Scholar 

  53. Mattoo S, Cherry JD. Molecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies. Clin Microbiol Rev 2005;18(2):326–382.

    Article  CAS  PubMed  Google Scholar 

  54. Locht C, Antoine R, Jacob-Dubuisson F. Bordetella pertussis, molecular pathogenesis under multiple aspects. Curr Opin Microbiol 2001;4(1):82–89.

    Article  CAS  PubMed  Google Scholar 

  55. Jenkinson D. Natural course of 500 consecutive cases of whooping cough: a general practice population study. BMJ 1995;310(6975):299–302.

    CAS  PubMed  Google Scholar 

  56. Ewanowich CA, Chui LW, Paranchych MG, et al. Major outbreak of pertussis in northern Alberta, Canada: analysis of discrepant direct fluorescent-antibody and culture results by using polymerase chain reaction methodology. J Clin Microbiol 1993;31(7):1715–1725.

    CAS  PubMed  Google Scholar 

  57. Loeffelholz MJ, Thompson CJ, Long KS, Gilchrist MJ. Comparison of PCR, culture, and direct fluorescent-antibody testing for detection of Bordetella pertussis. J Clin Microbiol 1999;37(9):2872–2876.

    CAS  PubMed  Google Scholar 

  58. Zetola N, Francis JS, Nuermberger EL, Bishai WR. Community-acquired methicillin-resistant Staphylococcus aureus: an emerging threat. Lancet Infect Dis 2005;5(5):275–286.

    Article  PubMed  Google Scholar 

  59. Lina G, Piemont Y, Godail-Gamot F, et al. Involvement of Panton-Valentine leukocidin-producing Staphylococcus aureus in primary skin infections and pneumonia. Clin Infect Dis 1999;29(5):1128–1132.

    Article  CAS  PubMed  Google Scholar 

  60. Fey PD, Said-Salim B, Rupp ME, et al. Comparative molecular analysis of community-or hospital-acquired methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 2003;47(1):196–203.

    Article  CAS  PubMed  Google Scholar 

  61. Palavecino E. Community-acquired methicillin-resistant Staphylococcus aureus infections. Clin Lab Med 2004;24(2):403–418.

    Article  PubMed  Google Scholar 

  62. Kuehnert MJ, Doyle TJ, Hill HA, et al. Clinical features that discriminate inhalational anthrax from other acute respiratory illnesses. Clin Infect Dis 2003;36(3):328–336.

    Article  PubMed  Google Scholar 

  63. Karwa M, Currie B, Kvetan V. Bioterrorism: preparing for the impossible or the improbable. Crit Care Med 2005;33(1 Suppl):S75–S95.

    Article  PubMed  Google Scholar 

  64. Greenfield RA, Bronze MS. Prevention and treatment of bacterial diseases caused by bacterial bioterrorism threat agents. Drug Discov Today 2003;8(19):881–888.

    Article  CAS  PubMed  Google Scholar 

  65. Lim DV, Simpson JM, Kearns EA, Kramer MF. Current and developing technologies for monitoring agents of bioterrorism and biowarfare. Clin Microbiol Rev 2005;18(4):583–607.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Infectious Diseases, Cleveland Clinic, Cleveland, OH, USA

    Nabin K. Shrestha MD (Associate Staff Physician)

  2. Clinical Microbiology, Department of Clinical Pathology, Cleveland Clinic, Cleveland, OH, USA

    Gary W. Procop MD (Section Head)

Authors
  1. Nabin K. Shrestha MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Gary W. Procop MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Pathology, Penn State Milton S. Hershey Medical Center, Hershey, PA, USA

    Dani S. Zander MD

  2. Institute of Pathology, Laboratories for Molecular Cytogenetics, Medical University of Graz, Graz, Austria

    Helmut H. Popper MD

  3. Department of Pathology, University of Texas Health Science Center, San Antonio, TX, USA

    Jaishree Jagirdar MD

  4. Weill Medical College of Cornell University, New York, NY

    Abida K. Haque MD

  5. Department of Pathology, San Jacinto Methodist Hospital, Baytown, TX, USA

    Abida K. Haque MD

  6. Pathology and Laboratory Medicine, Weill Medical College of Cornell University, New York, NY

    Philip T. Cagle MD  & Roberto Barrios MD  & 

  7. The Methodist Hospital, Houston, TX, USA

    Philip T. Cagle MD  & Roberto Barrios MD  & 

Rights and permissions

Reprints and permissions

Copyright information

© 2008 Springer Science+Business Media, LLC.

About this chapter

Cite this chapter

Shrestha, N.K., Procop, G.W. (2008). Bacteria. In: Zander, D.S., Popper, H.H., Jagirdar, J., Haque, A.K., Cagle, P.T., Barrios, R. (eds) Molecular Pathology of Lung Diseases. Molecular Pathology Library, vol 1. Springer, New York, NY. https://doi.org/10.1007/978-0-387-72430-0_39

Download citation

  • DOI: https://doi.org/10.1007/978-0-387-72430-0_39

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-0-387-72429-4

  • Online ISBN: 978-0-387-72430-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation